ArticleCardiovascular diagnosis and therapy2026
Clinical predictors and prognostic implications of HFpEF following STEMI based on HFA-PEFF score: a multicenter cohort analysis.
Article in Cardiovascular diagnosis and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: ST-segment elevation myocardial infarction (STEMI) is usually associated with impaired systolic function, but heart failure with preserved ejection fraction (HFpEF) may also occur and remains under-recognized in this setting. We aimed to investigate the prevalence, clinical predictors, and outcomes of HFpEF in STEMI patients with preserved left ventricular ejection fraction (LVEF). Methods: We retrospectively analyzed 421 STEMI patients who underwent successful percutaneous coronary intervention (PCI). Among them, 280 patients with LVEF ≥50% on 1-month follow-up echocardiography were included. Patients were classified as HFpEF or non-HFpEF according to the Heart Failure Association Pre-test assessment, Echocardiography and natriuretic peptide, Functional testing, Final etiology (HFA-PEFF) score, with scores ≥5 defining HFpEF. The primary endpoint was a composite of cardiovascular (CV) death or hospitalization for heart failure (HF). Results: Eighty-eight patients (31.4%) were classified as HFpEF. Compared with the non-HFpEF group, these patients were older (mean age 70 years), more frequently female (46.6% Conclusions: In STEMI patients with preserved LVEF, a substantial proportion developed HFpEF, which was associated with increased risks of HF hospitalization and mortality. The HFA-PEFF score provides incremental prognostic value in this population and may help identify high-risk patients for closer monitoring and tailored management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.